DevicePharm is a sponsor of the 3rd Annual MedDev eMarketing Summit, West. Jon Hermie and Clay Wilemon will be presenting a session titled: “Optimizing Consumer Digital Engagement and Conversion – Lessons Learned in Elective Medical Procedure Marketing”.
Medical Marketing Strategy Agency | DevicePharm
DevicePharm has been recognized as a Foundational Member of Medical Alley, the Minnesota-based organization focused on growing one of the world’s most prolific centers of healthcare technology and delivery innovation.
Any marketer that has conducted a direct-to-consumer (DTC) campaign understands the challenge of consumer engagement, especially web engagement. How do you meaningfully engage with interested visitors who are browsing your website in a world of 24/7 communication expectations?
Millions of Americans have considered weight loss surgery but made the decision that although they wanted significant weight loss, surgery was too big of a step for them. Now, with the U.S. FDA’s approval of the ReShape™ Integrated Dual Balloon System, a non-surgical weight loss procedure is available in the United States. It is called theReShape Procedure and is indicated for people with a BMI of 30 to 40.
What if you could focus your marketing plans and messaging only on the people who were actually going to buy your product or service?” This was the question posed by Clay Wilemon, DevicePharm CEO & Chief Strategy Officer, to an enthusiastic audience in San Diego during the September Device Alliance meeting.
The reality is that using predictive analytics in market research is providing a more precise way of targeting, messaging, and selling to the customers who are actually going to buy your products.
To preserve editorial accuracy, let it be known to one and all that DevicePharm is not currently, nor have we ever been, an “ad agency.” Traditional or otherwise.